![](https://tracker.live.rns-distribution.com/track.live-rns/5283105_d9353a075fe0b610698e373da828b7e4.png)
FORM 8.3 - Amendment to 2a and 3a | |||||||
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY | |||||||
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR | |||||||
MORE | |||||||
Rule 8.3 of the Takeover Code (the "Code") | |||||||
1. | KEY INFORMATION | ||||||
(a) | Full name of discloser: | Barclays PLC. | |||||
(b) | Owner or controller of interest and short |
| |||||
(c) | Name of offeror/offeree in relation to whose | HIPGNOSIS SONGS FUND LTD/THE FUND | |||||
(d) | If an exempt fund manager connected with an |
| |||||
(e) | Date position held/dealing undertaken: | 18 Jul 2024 | |||||
(f) | In addition to the company in 1(c) above, is the discloser making | NO | |||||
2. | POSITIONS OF THE PERSON MAKING THE DISCLOSURE | ||||||
(a) | Interests and short positions in the relevant securities of the offeror or offeree | ||||||
Class of relevant security: | ordinary | ||||||
| Interests | Short Positions | |||||
Number | (%) | Number | (%) | ||||
(1) Relevant securities owned and/or controlled: | 29,480,974 | 2.44% | 108,494 | 0.01% | |||
(2) Cash-settled derivatives: | 3 | 0.00% | 29,153,926 | 2.41% | |||
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||
| 29,480,977 | 2.44% | 29,262,420 | 2.42% | |||
(b) | Rights to subscribe for new securities (including directors and | ||||||
Class of relevant security in relation to | | ||||||
Details, including nature of the rights | | ||||||
3. | DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE | ||||||
(a) | Purchase and sales | ||||||
Class of relevant | Purchase/sale | Number of | Price per unit | ||||
ordinary | Purchase | 185,147 | 1.0060 GBP | ||||
ordinary | Purchase | 85,773 | 1.0028 GBP | ||||
ordinary | Purchase | 22,657 | 1.0038 GBP | ||||
ordinary | Purchase | 9,682 | 1.0053 GBP | ||||
ordinary | Purchase | 9,187 | 1.0055 GBP | ||||
ordinary | Purchase | 5,210 | 1.0040 GBP | ||||
ordinary | Purchase | 5,082 | 1.0054 GBP | ||||
ordinary | Purchase | 4,128 | 1.0020 GBP | ||||
ordinary | Purchase | 1,743 | 1.0037 GBP | ||||
ordinary | Purchase | 1,540 | 1.0059 GBP | ||||
ordinary | Purchase | 767 | 1.0031 GBP | ||||
ordinary | Purchase | 653 | 1.0041 GBP | ||||
ordinary | Purchase | 380 | 1.0032 GBP | ||||
ordinary | Sale | 219,207 | 1.0060 GBP | ||||
ordinary | Sale | 64,168 | 1.0065 GBP | ||||
ordinary | Sale | 54,364 | 1.0058 GBP | ||||
ordinary | Sale | 2,470 | 1.0040 GBP | ||||
(b) | Cash-settled derivative transactions | ||||||
Class of | Product description | Nature of dealing | Number of | Price per | |||
ordinary | CFD | Increasing Short | 6,598 | 1.0028 GBP | |||
ordinary | CFD | Increasing Short | 42,813 | 1.0030 GBP | |||
| | | | | | | |
(c) | Stock-settled derivative transactions | ||||||
(i) | Writing, selling, purchasing or varying | ||||||
Class | Product | Writing, | Number | Exercise | Type | Expiry | Option |
| | | | | | | |
| | | | | | | |
(ii) | Exercising |
| | | | | |
Class of relevant | Product description | Exercising/ exercised against | Number of | Exercise price per | |||
| | | | | |||
| | | | | | | |
(d) | Other dealings (including subscribing for | ||||||
Class of relevant | Nature of Dealings | Details | Price per unit (if | ||||
| | | | ||||
4. | OTHER INFORMATION | ||||||
(a) | Indemnity and other dealings arrangements | ||||||
Details of any indemnity or option arrangement, or any agreement or understanding, | |||||||
NONE | |||||||
(b) | Agreements, arrangements or understandings relating to options or | ||||||
Details of any agreement, arrangement or understanding, formal or informal, between | |||||||
NONE | |||||||
(c) | Attachments |
| | | | | |
Is a Supplemental Form 8 (Open Positions) attached? | NO | ||||||
Date of disclosure: | 26 Jul 2024 | ||||||
Contact name: | Large Holdings Regulatory Operations | ||||||
Telephone number: | 020 3134 7213 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.